3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
20
Myelodysplastic Syndromes
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Leukemia, Biphenotypic, Acute
5
Hodgkin Disease
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Myeloproliferative Disorders
4
Lymphoma, Non-Hodgkin
4
Burkitt Lymphoma
4
Recurrence
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia
3
Hematologic Neoplasms
3
Neuroblastoma
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Transplant-Related Hematologic Malignancy
1
Teratoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Primary Myelofibrosis
1
Neoplasms by Histologic Type
1
Neoplasms
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Interventions
gallium Ga 68 dotatate
1
Temozolomide
1
Standard of Care
1
Radiotherapy
1
Nivolumab
1
Eflornithine
1
Drug Therapy
1
CLR1404
1
Blood Specimen Collection
1
Automobiles
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Granulocyte Colony-Stimulating Factor
×
90 days
×
Clear all
No trials found.